Market Highlights
Single-Photon Emission Computed Tomography
Market Share is expected to reach at 6.90% CAGR during the
forecast period 2023-2032.
The growing acceptance of Single-Photon Emission
Computed Tomography (SPECT) accustomed by its technical advances is one of the
major trends witnessed in the global SPECT market over the forecast period.
Imaging devices are becoming more advanced, efficient, and evolved in terms of
technology. The SPECT scanner has two integral parts namely computed tomography
(CT) and a radioactive material (tracer). Basically, these tracers are used to
diagnose and predict outcomes in various disease states by monitoring the
therapeutic effects.
The Single-Photon
Emission Computed Tomography market insights is expected to witness
tremendous growth owing to the new 99mtc labelled agents for visualizing
biologically significant events, and integration of X-ray tomography (CT) In
SPECT. Other key factors such significant investments in R&D and expansions
undertaken by key players are contributing towards the growth of the market.
However, challenges such as need for skilled professionals, and reimbursement
issues, is likely to curb the market growth during the forecast period.
Key players
The global market is manifested with the presence of limited
companies, leading to the consolidated nature of the market. The industry
rivalry are expected to remain high throughout the forecast period. Several
small and larger companies are involved in development of Single-Photon
Emission Computed Tomography (SPECT) for diagnostic applications.
The Single-Photon Emission Computed
Tomography Market Players are GE Healthcare, Siemens
Healthcare, Koninklijke Philips N.V., Bruker
Corporation, Mediso Ltd., Digirad Corporation, Spectrum Dynamics Medical,
DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing Hamamatsu Photon
Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
PNPMedM,
NuCare Inc., and others.
Segmentation
The global Single-Photon
Emission Computed Tomography market outlook is segmented into
type, application, end-users. The Single-Photon Emission Computed Tomography
(SPECT) market, by type, the market is segmented into hybrid SPECT systems, and
standalone SPECT systems. On the basis of application, the Single-Photon
Emission Computed Tomography (SPECT) market is bifurcated into oncology,
cardiology, neurology, and others. On the basis of end-user, the market is
segmented into hospitals, diagnostic imaging centers, academic & research
centers, and others.
Regional Analysis
The Americas is the largest in the market owing to the
improving research infrastructure in the region, coupled with the rising
awareness among patients and physicians for radioisotopes. Further, SPECT has
reportedly been combined with CT and MRI to provide detailed anatomical and
metabolic information. It is currently exhibiting a highly lucrative growth
rate due to an increased use of SPECT for diagnosis of cardiac diseases, brain
diseases, etc.
The European region is the second largest SPECT market
over the forecast period due to high acceptance of SPECT in research &
development along with the rising incidence of chronic disease like cancers are
also accountable for the growth of the Single-Photon Emission Computed
Tomography (SPECT) market.
The Asia Pacific region is likely to develop at the
uppermost CAGR for the Single-Photon Emission Computed Tomography (SPECT)
market in the years to come. Moreover, the rising diagnostic care services both
at the hospitals and at community level are expected to influence the market in
a positive way. The Middle East and Africa accounts for the least market share
due to low per capita income and lack of availability of well-trained
healthcare professionals.
About US:
Market Research Future (MRFR), enable customers to unravel the
complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
